Eaton Vance Management boosted its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 29.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 108,449 shares of the medical instruments supplier’s stock after purchasing an additional 24,909 shares during the quarter. Eaton Vance Management owned about 0.53% of ICU Medical worth $30,664,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the stock. Martingale Asset Management L P raised its stake in ICU Medical by 452.0% during the third quarter. Martingale Asset Management L P now owns 137,485 shares of the medical instruments supplier’s stock worth $38,875,000 after acquiring an additional 112,577 shares in the last quarter. BlackRock Inc. raised its stake in ICU Medical by 8.3% during the third quarter. BlackRock Inc. now owns 1,431,253 shares of the medical instruments supplier’s stock worth $404,685,000 after acquiring an additional 109,396 shares in the last quarter. FMR LLC raised its stake in ICU Medical by 87.4% during the third quarter. FMR LLC now owns 218,602 shares of the medical instruments supplier’s stock worth $61,810,000 after acquiring an additional 101,972 shares in the last quarter. American Century Companies Inc. acquired a new position in ICU Medical during the third quarter worth about $25,882,000. Finally, First Trust Advisors LP raised its stake in ICU Medical by 436.0% during the third quarter. First Trust Advisors LP now owns 108,440 shares of the medical instruments supplier’s stock worth $30,661,000 after acquiring an additional 88,207 shares in the last quarter. 75.97% of the stock is owned by institutional investors and hedge funds.
In other news, Director Pfizer Inc sold 2,500,000 shares of the company’s stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $209.25, for a total value of $523,125,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 12.50% of the company’s stock.
ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.34. ICU Medical had a return on equity of 15.20% and a net margin of 6.00%. The company had revenue of $327.20 million during the quarter, compared to the consensus estimate of $334.97 million. During the same quarter in the prior year, the firm posted $1.12 earnings per share. The firm’s revenue was down 4.7% compared to the same quarter last year. Analysts expect that ICU Medical, Incorporated will post 7.76 EPS for the current fiscal year.
Several brokerages have commented on ICUI. TheStreet raised ICU Medical from a “c+” rating to a “b+” rating in a research note on Monday, August 20th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $337.00 target price for the company in a research note on Wednesday, August 15th. ValuEngine raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Finally, BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 28th.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2018/12/03/eaton-vance-management-has-30-66-million-position-in-icu-medical-incorporated-icui.html.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: What is a Swap?
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.